Drugs / Lybrel
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | LYBREL | — | 2007-05-22 | fda.gov ↗ |
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00480532 Background | May 2007 → Jan 2010 | — | Oregon Health and Science University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lybrel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00480532 ↗ |
| Route | Oral | “same daily low dose oral contraceptive (20-mcg EE/90 mcg LNG) dosed in a continuous fashion” NCT00480532 ↗ |